Moffitt logo

Clinical Trials Search

Clinical Trial 20113

Cancer Type: Malignant Hematology
Study Type: Treatment
NCT#: NCT03761108

Phase: Phase I
Prinicipal Investigator:

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Phase 1/2 FIH Study of Regn5458 (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Patients with Relapsed or Refractory Multiple Myeloma

Summary

Objective

Treatments

Therapies

Medications

REGN5458 ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.